MedTrace Logo

A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis

NCT01132677 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2010-05-28

No results posted yet for this study

Summary

Do differences exist between patients who receive a single intra-articular injection of corticosteroid versus patients who receive a single intra-articular injection of hyaluronic acid for the treatment of knee osteoarthritis at 1, 3 and 6 weeks, and 3 and 6 months post injection?

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Hylan G-F 20 (Synvisc One)

Single IA injection of 6cc's. Injections will be administered as outlined on the company label.

DRUG

Methylprednisolone (Corticosteroid)

Single IA injection of 80mg of methylprednisolone acetate (1cc of solution) mixed with 5cc's of 1% lidocaine without epinephrine for a total of 6cc's. The injection will be administered as outlined on the company label.

Sponsors & Collaborators

  • LifeMark Health

    lead OTHER

Principal Investigators

  • Brad J Monteleone, Physician · UBC - Department of Family Practice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-05-31
Completion
2011-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01132677 on ClinicalTrials.gov